Viewing Study NCT00017303


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2025-12-25 @ 5:26 PM
Study NCT ID: NCT00017303
Status: UNKNOWN
Last Update Posted: 2013-11-06
First Post: 2001-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
Sponsor: Cytran
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module